press release archive

Current \| 2007 \| 2006 \| 2005 \| 2004 \| 2003 \| 2002 \| 2001 \| 2000 \| 1999 \| 1998 \| 1997
12/27/2000		Rigel Pharmaceuticals Announces Exercise of Over-Allotment Option

11/28/2000		Rigel Pharmaceuticals Announces Pricing of Initial Public Offering

9/25/2000		Rigel Receives Patent for Mammalian Two-Hybrid Technology

9/15/2000		Rigel Files Registration Statement for Initial Public Offering of Common Stock

8/24/2000		Rigel and Novartis Initiate Third Drug Discovery Collaboration

8/21/2000		Rigel Appoints Thomas S. Volpe to Board of Directors

7/12/2000		Rigel Appoints Susan Molineaux, PH.D. Senior Director, Combinatorial Biology

5/1/2000		Rigel Appoints Raul Rodriquez Vice President Business Development

4/13/2000		Rigel Pharmaceuticals Withdraws Initial Public Offering

3/8/2000		Rigel Uncovers Function of a Key Protein Involved in Production of Antibodies That Can Cause Allergies and Autoimmune Diseases


© 2013 Rigel \| privacy \| disclaimer \| Follow Us On:	contact us \| site map \| search